These results suggested that upregulation of IDO in breast cancer cells may lead to increased recruitment of CD4+CD25+ Tregs into the tumor microenvironment and thus inhibit the local immune surveillance and promote metastasis. This evidence concerns the gene IDO1 and breast carcinoma.